News
4h
Stockhead on MSNControl Bionics’ growth bounces aheadControl Bionics reports traction across its core product platforms with growing international partnerships and increasing ...
6h
Stockhead on MSNHealth Check: Telix licks its wounds after FDA knocks back brain cancer diagnosticTelix Pharmaceuticals has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain ...
House Republicans are under the gun to get specific on how they will offset President Trump’s domestic policy agenda, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results